Genprex, Inc. (GNPX) Stock Price, News, Quote & History

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},m=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){Le(c)||u()})),c&&(m(),setInterval((function(){m()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var f=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(eo=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===f&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Gt)),notifLabel:document.querySelector(".".concat(Wt))};to(e,n)}))}()}};

NasdaqCM - Delayed Quote • USD

Compare

1.4700 -0.0900 (-5.77%)

At close: August 5 at 4:00 PM EDT

1.5800 +0.07 (+4.64%)

Pre-Market: 8:22 AM EDT

Key Events

Line

Candle

Baseline

Mountain

Bar

Advanced Chart

Loading Chart for GNPX

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

Previous Close 1.5600
Open 1.5300
Bid --
Ask --
Day's Range 1.4400 - 1.5399
52 Week Range 1.4400 - 28.8400
Volume 26,069
Avg. Volume 103,362
Market Cap (intraday) 3.085M
Beta (5Y Monthly) -0.51
PE Ratio (TTM) --
EPS (TTM) -18.8100
Earnings Date Aug 21, 2024 - Aug 26, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 165.00

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

www.genprex.com

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Genprex, Inc.

Recent News: GNPX

All SEC Filings

Corporate Changes & Voting Matters

Periodic Financial Reports

Proxy Statements

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

GNPXGenprex, Inc.

1.4700

-5.77%

Mkt Cap 3.085M

Industry Biotechnology

RVPHReviva Pharmaceuticals Holdings, Inc.

0.9455

-6.39%

Mkt Cap 28.192M

Industry Biotechnology

CINGCingulate Inc.

0.2950

-5.21%

Mkt Cap 3.085M

Industry Biotechnology

CRDFCardiff Oncology, Inc.

2.0650

-7.81%

Mkt Cap 92.382M

Industry Biotechnology

MISTMilestone Pharmaceuticals Inc.

1.2900

-3.73%

Mkt Cap 68.718M

Industry Biotechnology

SNSESensei Biotherapeutics, Inc.

0.6100

-2.24%

Statistics: GNPX

Valuation Measures

Annual

As of 8/5/2024

Market Cap

3.09M
Enterprise Value

-5.13M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

0.35
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

0.18

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-96.86%
Return on Equity (ttm)

-202.83%
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-27.63M
Diluted EPS (ttm)

-18.8100

Balance Sheet and Cash Flow

Total Cash (mrq)

8.22M
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

-13.02M

Research Analysis: GNPX

Company Insights: GNPX

Research Reports: GNPX

People Also Watch

DARE Daré Bioscience, Inc.

3.2628

-1.72%

CODX Co-Diagnostics, Inc.

1.0500

-3.67%

COCP Cocrystal Pharma, Inc.

1.7450

-4.64%

AIM AIM ImmunoTech Inc.

0.3226

-8.25%

AYTU Aytu BioPharma, Inc.

2.4300

-3.19%

OPGN OpGen, Inc.

2.5799

-8.84%

VTVT vTv Therapeutics Inc.

14.53

-1.22%

AGRX Agile Therapeutics, Inc.

1.4600

-0.68%

NNVC NanoViricides, Inc.

2.0200

-3.81%

CTXR Citius Pharmaceuticals, Inc.

0.9324

+2.86%

PIXY ShiftPixy, Inc.

1.2100

-12.32%

CAPR Capricor Therapeutics, Inc.

3.7700

-3.08%

CLSD Clearside Biomedical, Inc.

1.0900

-1.80%

HOTH Hoth Therapeutics, Inc.

0.6289

-10.62%

BSGM BioSig Technologies, Inc.

0.3410

+2.71%

VBIV VBI Vaccines Inc.

0.0629

-33.09%

Genprex, Inc. (GNPX) Stock Price, News, Quote & History - Yahoo Finance (2024)

Full Time Employees

Fiscal Year Ends

Sector

Industry

Profitability and Income Statement

Balance Sheet and Cash Flow